Development of novel immunotherapy-based therapies in oesophageal adenocarcinoma: are tumour neoantigens the answer?     (#18)
    
  
  
                                                                              
  James Lonie
      1
      2
  
, 
  Sandra Brosda
      1
  
, 
  Venkat Addala
      3
  
, 
  Nicola Waddell
      3
  
, 
  Riccardo Dolcetti
      1
      4
      5
  
, 
  Andrew Barbour
      1
      2
  
    
              - Frazer Institute, Faculty of Medicine, University of Queensland, Brisbane
- Upper Gastro-intestinal and Soft Tissue Unit, Princess Alexandra Hospital, Brisbane
- QIMR Berghoffer, Brisbane
- Clinical and Translational Immunotherapy , Peter MacCallum Cancer Centre, Melbourne
- University of Melbourne, Melbourne